Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

OSAKA, Japan and DEERFIELD, Ill. and FORT COLLINS, Colo., May 7, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and Inviragen, Inc. ("Inviragen") jointly announced today that Takeda, its wholly owned subsidiary Takeda America Holdings, Inc., and Inviragen, Inc. have entered into a definitive agreement for Takeda to acquire Inviragen for an upfront payment of US$35 million, and future payments of up to US$215 million linked to the progress of clinical development and achievement of key commercial milestones. Headquartered in Fort Collins, CO, with facilities in Madison, WI and Singapore, Inviragen is a privately-held biopharmaceutical company specializing in research and development of innovative vaccines for emerging infectious diseases, including dengue and hand, foot and mouth disease (HFMD).

"Takeda has taken another major step toward its goal of establishing a world-class global vaccine business by acquiring Inviragen and its advanced vaccine candidate against dengue, a serious mosquito-borne illness that threatens nearly half of the world's population," said Rajeev Venkayya, M.D., executive vice president and head of Takeda's Vaccine Business Division. "Today's announcement reinforces Takeda's commitment to develop innovative vaccines to fight some of the world's most important infectious diseases."

Inviragen has created innovative products using its expertise in viral vaccines. The company's lead candidate, DENVax, is a four-strain recombinant viral vaccine for the prevention of dengue infection. An administration schedule of two doses of DENVax over 90 days is currently being evaluated in Phase 2 clinical trials. In addition to DENVax, Inviragen's pipeline contains a vaccine candidate to protect against hand, foot and mouth disease (HFMD) caused by enterovirus 71 (EV71), which has compl
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Responds to Verdict in Diabetes Drug Case
2. Takeda Launches New Subsidiary in Ecuador
3. Takeda lanza nueva subsidiaria en Ecuador
4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014   LabStyle Innovations Corp . ... announced the appointment of Professor Richard B. ... Board of Directors. Prof. Stone brings ... to LabStyle as an entrepreneur, venture capitalist public, ... governance expert. He currently serves on the board ...
(Date:1/15/2014)... 2014 Most osteoporosis patients want a choice in ... survey* sponsored by Mission Pharmacal Company. The survey, conducted ... online support community, revealed that 74 percent of osteoporosis ... a form other than a pill or a tablet. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... , , JERUSALEM , ... Dr. Amatruda is the Former Senior Vice President and Franchise Head of,the ... Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com ), a,developer of oral ... Oramed,s Scientific Advisory Board, enhancing Oramed,s,talented and experienced scientific team. , ...
... , , MOUNTAIN VIEW, Calif. ... ) announced today that it will host an investor/analyst meeting on ... ET , in New York City . , The meeting will ... CEO, Alexza Pharmaceuticals James Cassella , PhD - ...
Cached Medicine Technology:Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 2Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4
(Date:7/11/2014)... 11, 2014 Ticket Down is a ... Pavilion . When it comes to the summer concert schedule, ... 37-year-old Georgia native is one of the biggest names in country ... Bryan is currently out on his “That’s My Kind of Night” ... the tour will be making through the rest of the summer ...
(Date:7/11/2014)... The report “Probiotics Market by Products (Functional Foods, ... Therapeutic, Preventive Health Care) & Ingredients (Lactobacilli, Bifidobacteria, ... ” defines and segments the global probiotics market ... value of probiotic products and ingredients. The report ... the global market with an analysis of trends, ...
(Date:7/11/2014)... Alliance for Cancer Gene Therapy, Inc. ... to cell and gene therapies for cancer – ... organization as Senior Development Officer. , Corday is ... gifts and addressing influential donors. Prior to joining ... NewYork Presbyterian Hospital/Columbia University Medical Center, where he ...
(Date:7/11/2014)... According to a new market research ... Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application ... Transportation, Agriculture) & Geography - Global Trends & Forecasts ... Things market was worth $1029.5 Billion in 2013, and ... an estimated CAGR of 4.08% from 2014 to 2020. ...
(Date:7/11/2014)... 11, 2014 Global enterprises today are ... outsource day-to-day management activities. Managed services offer these global ... The economic slowdown resulted into rising operational costs to ... is considered to be the global market driver for ... The global managed services market is estimated to grow ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4
... 2012) An overgrowth of bacteria in the gut has ... of a new Cedars-Sinai study which used cultures from the ... "gold standard" method of connecting bacteria to the cause of ... the United States. Previous studies have indicated that ...
... , THURSDAY, May 24 (HealthDay News) -- Only ... in from tobacco revenues goes to anti-smoking efforts, a new ... Agreement, tobacco companies agreed to reimburse states for Medicaid costs ... new study, the intent of the agreement was to use ...
... filters are often coated with colloidal silver, which prevents ... nano-scale pores of the filter. Other metals such as ... anti-microbial activity. Researchers from Princeton University in New Jersey ... adhesion interaction between Escherichia coli ( E. ...
... (HealthDay News) -- Japanese-American men who don,t eat a diet ... later in life, according to a new, long-term study. ... They were between the ages of 45 and 68 ... and interviewed about their eating habits. During 34 years ...
... how carbohydrates are converted into energy has led to ... a perplexing and potentially fatal neuromuscular disorder and possibly ... the cause of this neuromuscular disorder was unknown. But ... have the disorder, a team led by University of ...
... May 24 (HealthDay News) -- Fatigue is a common problem ... growing body of evidence suggests that fatigue may play a ... the Harvard Orthopaedic Combined Residency Program and Massachusetts General Hospital ... surgery residents who slept an average of 5.3 hours a ...
Cached Medicine News:Health News:Cedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut 2Health News:States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds 2Health News:States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds 3Health News:Pivotal role for proteins -- from helping turn carbs into energy to causing devastating disease 2
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. Designated most popular model or size....
Designated most popular model or size. Double-ended. 2 mm wide....
Desmarres Retractor Size 4...
Medicine Products: